These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7858907)

  • 1. Lipoprotein receptors and atherogenic receptor-mediated mechanisms.
    van Berkel TJ; Ziere GJ; Bijsterbosch MK; Kuiper J
    Curr Opin Lipidol; 1994 Oct; 5(5):331-8. PubMed ID: 7858907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDL receptor-independent and -dependent uptake of lipoproteins.
    van Berkel TJ; Fluiter K; van Velzen AG; Vogelezang CJ; Ziere GJ
    Atherosclerosis; 1995 Dec; 118 Suppl():S43-50. PubMed ID: 8821464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha 2-macroglobulin-recognition site.
    van Dijk MC; Ziere GJ; Boers W; Linthorst C; Bijsterbosch MK; van Berkel TJ
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):863-70. PubMed ID: 1719960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor and non-receptor mediated uptake of chylomicron remnants by the liver.
    Havel RJ
    Atherosclerosis; 1998 Dec; 141 Suppl 1():S1-7. PubMed ID: 9888635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the alpha 2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein on rat liver parenchymal cells by the 39-kDa receptor-associated protein leaves the interaction of beta-migrating very-low-density lipoprotein with the lipoprotein remnant receptor unaffected.
    Ziere GJ; van der Kaaden ME; Vogelezang CJ; Boers W; Bihain BE; Kuiper J; Kruijt JK; van Berkel TJ
    Eur J Biochem; 1996 Dec; 242(3):703-11. PubMed ID: 9022700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism.
    Havel RJ; Hamilton RL
    Hepatology; 1988; 8(6):1689-704. PubMed ID: 2847970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of lipoprotein receptors in atherosclerotic lesions.
    Hiltunen TP; Ylä-Herttuala S
    Atherosclerosis; 1998 Apr; 137 Suppl():S81-8. PubMed ID: 9694546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism.
    Beisiegel U
    Curr Opin Lipidol; 1995 Jun; 6(3):117-22. PubMed ID: 7647999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the chylomicron-remnant-recognition sites on parenchymal and Kupffer cells of rat liver. Selective inhibition of parenchymal cell recognition by lactoferrin.
    van Dijk MC; Ziere GJ; van Berkel TJ
    Eur J Biochem; 1992 Apr; 205(2):775-84. PubMed ID: 1315278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants.
    Argmann CA; Van Den Diepstraten CH; Sawyez CG; Edwards JY; Hegele RA; Wolfe BM; Huff MW
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2011-8. PubMed ID: 11742878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein binding to cultured human hepatoma cells.
    Krempler F; Kostner GM; Friedl W; Paulweber B; Bauer H; Sandhofer F
    J Clin Invest; 1987 Aug; 80(2):401-8. PubMed ID: 3038957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of chylomicrons into remnants.
    Hultin M; Olivecrona T
    Atherosclerosis; 1998 Dec; 141 Suppl 1():S25-9. PubMed ID: 9888638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of low-density lipoprotein and chylomicron remnants to the hepatic low-density lipoprotein receptor of dogs, rats and rabbits demonstrated by ligand blotting. Failure to detect a distinct chylomicron-remnant-binding protein by ligand blotting.
    Wade DP; Knight BL; Soutar AK
    Eur J Biochem; 1986 Sep; 159(2):333-40. PubMed ID: 3019686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias.
    Chait A
    Spec Top Endocrinol Metab; 1983; 5():1-53. PubMed ID: 6322371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the low-density-lipoprotein-receptor-independent interaction of beta-very-low-density lipoprotein with rat and human parenchymal liver cells in vitro.
    De Water R; Kamps JA; Van Dijk MC; Hessels EA; Kuiper J; Kruijt JK; Van Berkel TJ
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):41-8. PubMed ID: 1311560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chylomicron remnants: hepatic receptors and metabolism.
    Havel RJ
    Curr Opin Lipidol; 1995 Oct; 6(5):312-6. PubMed ID: 8520854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial lipoproteins and atherosclerosis.
    Yu KC; Cooper AD
    Front Biosci; 2001 Mar; 6():D332-54. PubMed ID: 11229885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages.
    Whitman SC; Hazen SL; Miller DB; Hegele RA; Heinecke JW; Huff MW
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1238-49. PubMed ID: 10323775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of LDL receptor by ligand blotting with chylomicron remnants labelled with colloidal gold.
    Pal S; Elsegood CL; Proctor SD; Mamo JC
    Ann Clin Biochem; 2000 Jul; 37 ( Pt 4)():471-8. PubMed ID: 10902863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake and catabolism of modified LDL in scavenger-receptor class A type I/II knock-out mice.
    Van Berkel TJ; Van Velzen A; Kruijt JK; Suzuki H; Kodama T
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):29-35. PubMed ID: 9512458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.